Russell Investments Group
SYNH

Russell Investments Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Russell Investments Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-382,471
Closed -$16.1M – 3662
2023
Q2 		$16.1M Sell
382,471
-564,461
-60% -$22.8M 0.03% 565
2023
Q1 		$33.7M Buy
946,932
+656,172
+226% +$23.8M 0.07% 351
2022
Q4 		$10.7M Buy
290,760
+163,014
+128% +$6.44M 0.02% 735
2022
Q3 		$6.02M Sell
127,746
-17,342
-12% -$1.12M 0.01% 965
2022
Q2 		$10.4M Buy
145,088
+14,925
+11% +$1.09M 0.02% 763
2022
Q1 		$10.5M Sell
130,163
-119,510
-48% -$10.1M 0.02% 815
2021
Q4 		$25.6M Buy
249,673
+2,262
+0.9% +$217K 0.04% 517
2021
Q3 		$21.6M Buy
247,411
+7,655
+3% +$693K 0.04% 557
2021
Q2 		$21.5M Sell
239,756
-77,749
-24% -$6.57M 0.04% 584
2021
Q1 		$24.1M Buy
317,505
+101,135
+47% +$7.62M 0.04% 503
2020
Q4 		$14.7M Buy
216,370
+807
+0.4% +$50.3K 0.03% 647
2020
Q3 		$11.5M Sell
215,563
-6,821
-3% -$406K 0.02% 693
2020
Q2 		$12.9M Buy
222,384
+28,037
+14% +$1.51M 0.03% 616
2020
Q1 		$7.66M Buy
194,347
+34,078
+21% +$1.99M 0.02% 754
2019
Q4 		$9.53M Buy
160,269
+6,766
+4% +$364K 0.02% 870
2019
Q3 		$8.17M Buy
153,503
+7,497
+5% +$385K 0.02% 950
2019
Q2 		$7.46M Sell
146,006
-1,490
-1% -$69.4K 0.01% 1027
2019
Q1 		$7.63M Buy
147,496
+7,663
+5% +$372K 0.01% 1030
2018
Q4 		$5.5M Sell
139,833
-4,269
-3% -$198K 0.01% 1096
2018
Q3 		$7.43M Buy
144,102
+24,262
+20% +$1.19M 0.01% 1094
2018
Q2 		$5.62M Sell
119,840
-53,504
-31% -$2.21M 0.01% 1222
2018
Q1 		$6.15M Buy
173,344
+157,458
+991% +$6.17M 0.01% 1240
2017
Q4 		$695K Sell
15,886
-369,534
-96% -$17.3M ﹤0.01% 2318
2017
Q3 		$20.2M Sell
385,420
-264,414
-41% -$14.7M 0.03% 633
2017
Q2 		$38M Buy
649,834
+56,405
+10% +$2.93M 0.07% 354
2017
Q1 		$27.2M Sell
593,429
-157,215
-21% -$7.82M 0.05% 451
2016
Q4 		$39M Buy
+750,644
New +$36.3M 0.08% 316

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Russell Investments Group's SYNH Position: Q3 2023 in Review

Russell Investments Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 382,471 shares — an estimated $16.1M sold.

Russell Investments Group first reported a position in SYNH in Q4 2016 and held it in 27 quarters. The position peaked at $39M in Q4 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Russell Investments Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Russell Investments Group sold 382,471 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $16.1M.
  • Russell Investments Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 27 quarters.
  • Russell Investments Group's Syneos Health, Inc. Class A Common Stock position peaked at $39M in Q4 2016.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.